Merilog is the third insulin biosimilar product approved by the FDA and joins the two long-acting insulin biosimilar products approved in 2021 by the FDA. Approval of biosimilar products can increase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback